Inhibition of Human Immunodeficiency Virus Type 1 Entry in Cells Expressing gp41-Derived Peptides

As the limitations of antiretroviral drug therapy, such as toxicity and resistance, become evident, interest in alternative therapeutic approaches for human immunodeficiency virus (HIV) infection is growing. We developed the first gene therapeutic strategy targeting entry of a broad range of HIV typ...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:J Virol
Main Authors: Egelhofer, Marc, Brandenburg, Gunda, Martinius, Holger, Schult-Dietrich, Patricia, Melikyan, Gregory, Kunert, Renate, Baum, Christopher, Choi, Ingrid, Alexandrov, Alexander, von Laer, Dorothee
Formato: Artigo
Idioma:Inglês
Publicado: American Society for Microbiology (ASM) 2004
Assuntos:
Vaccines and Antiviral Agents
Acceso en liña:https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC368739/
https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/14694088/
https://ncbi.nlm.nih.govhttps://doi.org/10.1128/JVI.78.2.568-575.2004
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares